Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics

One of the major issues encountered during the coronavirus disease 2019 (COVID-19) pandemic has been the shortage of intravenous anesthetics. Moreover, patients undergoing extracorporeal membrane oxygenation (ECMO) need large quantities of intravenous anesthetics for sedation. We report the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki, Yudai, Shiga, Takuya, Hoshi, Naoki, Irimada, Daisuke, Saito, Hidehisa, Konno, Daisuke, Saito, Koji, Yamauchi, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212718/
https://www.ncbi.nlm.nih.gov/pubmed/35780572
http://dx.doi.org/10.1016/j.hrtlng.2022.06.015
_version_ 1784730668549275648
author Iwasaki, Yudai
Shiga, Takuya
Hoshi, Naoki
Irimada, Daisuke
Saito, Hidehisa
Konno, Daisuke
Saito, Koji
Yamauchi, Masanori
author_facet Iwasaki, Yudai
Shiga, Takuya
Hoshi, Naoki
Irimada, Daisuke
Saito, Hidehisa
Konno, Daisuke
Saito, Koji
Yamauchi, Masanori
author_sort Iwasaki, Yudai
collection PubMed
description One of the major issues encountered during the coronavirus disease 2019 (COVID-19) pandemic has been the shortage of intravenous anesthetics. Moreover, patients undergoing extracorporeal membrane oxygenation (ECMO) need large quantities of intravenous anesthetics for sedation. We report the case of a 52-year-old man who was admitted to our hospital due to acute respiratory distress syndrome by COVID-19 and treated with ECMO. As controlling sedation with intravenous anesthetics was challenging, we attempted to administer inhaled anesthetics via the gas flow of ECMO. We decreased the quantity of intravenous anesthetics and opioids. This method might help overcome the shortage of intravenous anesthetics.
format Online
Article
Text
id pubmed-9212718
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92127182022-06-22 Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics Iwasaki, Yudai Shiga, Takuya Hoshi, Naoki Irimada, Daisuke Saito, Hidehisa Konno, Daisuke Saito, Koji Yamauchi, Masanori Heart Lung Article One of the major issues encountered during the coronavirus disease 2019 (COVID-19) pandemic has been the shortage of intravenous anesthetics. Moreover, patients undergoing extracorporeal membrane oxygenation (ECMO) need large quantities of intravenous anesthetics for sedation. We report the case of a 52-year-old man who was admitted to our hospital due to acute respiratory distress syndrome by COVID-19 and treated with ECMO. As controlling sedation with intravenous anesthetics was challenging, we attempted to administer inhaled anesthetics via the gas flow of ECMO. We decreased the quantity of intravenous anesthetics and opioids. This method might help overcome the shortage of intravenous anesthetics. Elsevier Inc. 2022 2022-06-16 /pmc/articles/PMC9212718/ /pubmed/35780572 http://dx.doi.org/10.1016/j.hrtlng.2022.06.015 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Iwasaki, Yudai
Shiga, Takuya
Hoshi, Naoki
Irimada, Daisuke
Saito, Hidehisa
Konno, Daisuke
Saito, Koji
Yamauchi, Masanori
Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
title Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
title_full Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
title_fullStr Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
title_full_unstemmed Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
title_short Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
title_sort sevoflurane administration from extracorporeal membrane oxygenation via the anaconda device for a patient with covid-19: a breakthrough solution for the shortage of intravenous anesthetics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212718/
https://www.ncbi.nlm.nih.gov/pubmed/35780572
http://dx.doi.org/10.1016/j.hrtlng.2022.06.015
work_keys_str_mv AT iwasakiyudai sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT shigatakuya sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT hoshinaoki sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT irimadadaisuke sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT saitohidehisa sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT konnodaisuke sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT saitokoji sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics
AT yamauchimasanori sevofluraneadministrationfromextracorporealmembraneoxygenationviatheanacondadeviceforapatientwithcovid19abreakthroughsolutionfortheshortageofintravenousanesthetics

Ejemplares similares